Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity

IF 2.6 3区 医学 Q3 ONCOLOGY Seminars in Radiation Oncology Pub Date : 2024-09-11 DOI:10.1016/j.semradonc.2024.08.001
Mu-Han Lin, Mona Arbab, Arnold Pompos, LaChandra Wilcox, Sepeadeh Radpour, Kajal Desai, Robert Timmerman
{"title":"Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity","authors":"Mu-Han Lin,&nbsp;Mona Arbab,&nbsp;Arnold Pompos,&nbsp;LaChandra Wilcox,&nbsp;Sepeadeh Radpour,&nbsp;Kajal Desai,&nbsp;Robert Timmerman","doi":"10.1016/j.semradonc.2024.08.001","DOIUrl":null,"url":null,"abstract":"<div><p>Radiation oncology caregivers worldwide are dedicated to advancing cancer treatment with the ultimate goal of eradicating the disease. Recognizing the inherent complexity of cancer treatment using hypo-fractionation radiotherapy (HFRT), these caregivers are committed to exploring avenues for progress and providing personalized care to each patient. Strong teams and effective workflows are an essential component to implementing safe HFRT. Every patient presents unique challenges, and as a united team of clinical and administrative professionals, radiation oncology care teams strive to drive advancements and streamline complexities in their field, guided by continuous technological innovation.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 4","pages":"Pages 395-401"},"PeriodicalIF":2.6000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1053429624000651/pdfft?md5=8512d5e175785b80c7b4c298011da84c&pid=1-s2.0-S1053429624000651-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1053429624000651","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Radiation oncology caregivers worldwide are dedicated to advancing cancer treatment with the ultimate goal of eradicating the disease. Recognizing the inherent complexity of cancer treatment using hypo-fractionation radiotherapy (HFRT), these caregivers are committed to exploring avenues for progress and providing personalized care to each patient. Strong teams and effective workflows are an essential component to implementing safe HFRT. Every patient presents unique challenges, and as a united team of clinical and administrative professionals, radiation oncology care teams strive to drive advancements and streamline complexities in their field, guided by continuous technological innovation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在多种多样的技术中实现安全的低分切技术:利用团队合作管理复杂性
全世界的肿瘤放射治疗人员都致力于推进癌症治疗,最终目标是根除癌症。由于认识到使用低分次放射治疗(HFRT)进行癌症治疗的内在复杂性,这些护理人员致力于探索取得进展的途径,并为每位患者提供个性化护理。强大的团队和有效的工作流程是实施安全 HFRT 的重要组成部分。每一位患者都面临着独特的挑战,作为一支由临床和行政专业人员组成的团结团队,肿瘤放射治疗团队以持续的技术创新为指导,努力推动这一领域的进步并简化其复杂性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
0.00%
发文量
48
审稿时长
>12 weeks
期刊介绍: Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
期刊最新文献
Radiation as an Immune Modulator: Where We Are With Modern Total Body Irradiation. Radiation for Multiple Myeloma in the Era of Novel Agents: Indications, Safety, and Dose Selection. Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma. Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship. Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1